BIOPLEX 2200 ANTI-CCP REAGENT PACK
Received Feb 22, 2023
Report 1000135116-2023-00001 · MDR key 16422988
Device
Generic name
Bioplex 2200 Anti-ccp
Manufacturer
Bio-rad Laboratories,incModel number
BIOPLEX 2200 ANTI-CCP REAGENT PACKCatalog number
665-3250
Lot number
301481
Product problems
- False Positive Result
- False Positive Result
Patient
Unknown
- No Clinical Signs, Symptoms or Conditions
- No Clinical Signs, Symptoms or Conditions
Narrative
Description of Event or Problem
BIO-RAD LABORATORIES HAS RECEIVED REPORTS OF DISCREPANT RESULTS WITH LOT NO. 301481 FROM FOUR CUSTOMERS PERFORMING LOT-TO-LOT VALIDATION AGAINST PREVIOUS LOTS. INTERNAL TESTING AT BIO-RAD HAS DEMONSTRATED THAT LOT NO. 301481 EXHIBITS A REDUCTION IN SPECIFICITY (POTENTIAL FOR FALSE POSITIVE RESULTS). THERE WERE NO REPORTED ADVERSE EVENT WITH THIS LOT. HOWEVER,FALSE POSITIVE ANTI-CCP RESULTS COULD LEAD TO INCORRECT DIAGNOSIS OF RHEUMATOID ARTHRITIS AND UNNECESSARY MEDICAL TREATMENT.
Additional Manufacturer Narrative
BIO-RAD LABORATORIES HAS RECEIVED REPORTS OF DISCREPANT RESULTS WITH LOT NO. 301481 FROM FOUR CUSTOMERS PERFORMING LOT-TO-LOT VALIDATION AGAINST PREVIOUS LOTS. INTERNAL TESTING AT BIO-RAD HAS DEMONSTRATED THAT LOT NO. 301481 EXHIBITS A REDUCTION IN SPECIFICITY. THE BIAS WAS OBSERVED ON THE LOW END OF THE ASSAY RANGE AND NONE OF THE FALSE POSITIVE RESULTS OBSERVED EXCEEDED 9 U/ML (3X CUT-OFF). THIS REDUCTION IN SPECIFICITY MAY LEAD TO AN INCREASE IN THE NUMBER OF FALSE POSITIVES AND COULD LEAD TO INCORRECT DIAGNOSIS OF RHEUMATOID ARTHRITIS AND UNNECESSARY MEDICAL TREATMENT.
Remedial action
- Recall
- Notification